Ipilimumab vs Minaprine
Ipilimumab vs Minaprine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Minaprine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Minaprine — Small molecule.